Letter: Azathioprine-induced pancreatitis and subsequent tolerance of mercaptopurine

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 4, 2014, Pages 440-

  Beswick, L ^a   Dowling, D ^a  

^a Barwon Health ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; IMMUNOSUPPRESSIVE AGENT;

DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; INFLAMMATORY BOWEL DISEASE; LETTER; PANCREATITIS; PRIORITY JOURNAL; CROHN DISEASE; FEMALE; MALE; NOTE; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 84892853215     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12584     Document Type: Letter

References (3)

1. Kennedy NA, Rhatigan E, Arnot IDR, et al,. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis. Aliment Pharmacol Ther 2013; 38: 1255-66.
2. Beswick L, Hair CS, Dowling D,. Successful mercaptopurine therapy after azathioprine-related pancreatitis in patients with IBD. Aliment Pharmacol Ther 2013; 37: 162.
3. Ledder OD, Lemberg DA, Ooi CY, et al,. Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease? J Pediatr Gastroenterol Nutr 2013; 57: 583-6.